Growing Body of Clinical Evidence Demonstrating Aurix’s Efficacy

Nuo Therapeutics, Inc. (NUOT – $0.26) earlier this week presented new clinical evidence that supports its leading-edge therapies for wound care. The Company’s star product, Aurix is the first platelet and plasma therapy system that’s cleared by the FDA for the management of ulcers and wounds of all types (diabetic foot ulcer, pressure ulcer, venous leg ulcer, etc.) and all […]

Read more

Cytomedix All Set To Capture U.S. Wound Care Market

Warning: this article contains images that some might find distressing. I’ll start this recommendation with a confession. I only like biotech and medical device companies after they’ve received regulatory approval. The trial process before a product or drug can be brought to the market, is just too time and money consuming for my taste. Even more importantly, despite fine test […]

Read more